Skip to main content
TipRanks
Go Ultimate75% OFF

Renalytix (2O9) Stock Forecast & Price Target

2 Followers
See the Price Targets and Ratings of:

2O9 Analyst Ratings

Currently, no data available

2O9 Stock 12 Month Forecast

There Are No Analyst Ratings for 2O9 In The Last 3 Months.

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for DE:2O9
Price TargetArticle
TipRanks - PerPlexity€0.04→€0.07hold6.36%UpsideReiterated11/02/26
TipRanks - Google€0.03→€0.07hold6.36%UpsideReiterated11/02/26
TipRanks - Anthropic€0.03→€0.06sell-3.31%DownsideReiterated11/02/26
TipRanks - OpenAI€0.03→€0.07hold6.36%UpsideReiterated11/02/26
TipRanks - DeepSeek€0.03→€0.07hold6.36%UpsideReiterated11/02/26
TipRanks - xAI€0.03→€0.07hold6.36%UpsideReiterated11/02/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
PTGXProtagonist Therapeutics
ESTAEstablishment Labs Holdings
MDWDMediwound
IMUXImmunic
OVIDOvid Therapeutics

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Renalytix

3 Months
Success Rate1/1 ratings generated profit
100%
Average Return
+60.30%

Copying Anthropic Medical - Healthcare Information Services's trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +60.30% per trade.

1 Year
Success Rate0/1 ratings generated profit
0%
Average Return
-5.10%

Copying Anthropic Medical - Healthcare Information Services's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -5.10% per trade.

2 Years
Success Rate0/1 ratings generated profit
0%
Average Return
-5.10%

Copying Anthropic Medical - Healthcare Information Services's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -5.10% per trade.

2O9 Analyst Recommendation Trends

00.511.52Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for 2O9
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy00000
Buy00000
Hold00000
Sell00000
Strong Sell00000
total00000

In the current month, 2O9 has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 2O9 average Analyst price target in the past 3 months is ―.

2O9 Financial Forecast

€-2€-1.5€-1€-0.5€0Q2 2025Q4 2026Q1 2027
Consensus€-0.01

2O9 Earnings Forecast

Next quarter’s earnings estimate for 2O9 is -EUR 0.01 with a range of ― to ―. The previous quarter’s EPS was -EUR 0.01. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

€480,476€717,790€955,104€1.2M€1.4MQ2 2025Q4 2026Q1 2027
Consensus€1.25M

2O9 Sales Forecast

Next quarter’s sales forecast for 2O9 is EUR 1.25M with a range of ― to ―. The previous quarter’s sales results were EUR 1.25M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

2O9 Stock Forecast FAQ

Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
What do analysts say about Renalytix?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of Renalytix?
To buy shares of DE:2O9, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.